NPI Details
DR. Lindsay Jo Orris, D.O. is an internal medicine in Bettendorf, IA with 17 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Lindsay Jo Orris, D.O. NPI is 1225263833. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
2979 VICTORIA ST
BETTENDORF, IA
ZIP 52722-784
Phone: (563) 359-4440
Fax: (563) 359-4644
The NPI 1225263833 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
- Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
- Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
- Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Liver enzyme (sgpt), level (HCPCS:84460)
- Liver enzyme (sgot), level (HCPCS:84450)
- Albumin (protein) level (HCPCS:82040)
- Blood creatinine level (HCPCS:82565)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
- Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Rheumatoid factor level (HCPCS:86431)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Aspiration and/or injection of fluid from large joint (HCPCS:20610)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Measurement of dna antibody, native or double stranded (HCPCS:86225)
- Measurement of dna antibody, single stranded (HCPCS:86226)
- Vitamin d-3 level (HCPCS:82306)
- Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
- Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
- X-ray of hand, 2 views (HCPCS:73120)
The enumeration date for this NPI number is 5/27/2009 and was last updated on 8/28/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 4321 | IOWA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 1303261 | MEDICAID | IOWA | |
| 2 | 1225263833 | OTHER | IOWA | BCBS OF IOWA |
